Clinical trial
Methotrexate in the Treatment of Axial Spondyloarthritis. A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study.
NCT00298012 is registered in ClinicalTrials.gov with Rheumatism Foundation Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Methotrexate in the Treatment of Axial Spondyloarthritis. A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study.
- Lead sponsor
- Rheumatism Foundation Hospital
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- March 31, 2006
- Completion date
- Not reported
- Enrollment
- 120 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.